This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Gambro
Gambro was a Swedish medical technology company active in kidney and liver dialysis, that had been acquired by a major European private equity firm. In 2012, the E3 Life team joined the senior management team to improve commercialisation and industrialisation.
The E3 Life team implemented commercial excellence programs to advance market penetration in its existing markets and pursued geographic expansion. Manufacturing and operational improvement programs were executed, along with a repositioning of the R&D pipeline towards technology leadership. Importantly, the E3 life team helped rescue the company from an earthquake-induced operational crisis.
The enhanced market and technology position of Gambro led to its successful acquisition by a major strategic acquirer for an attractive investment return.